Chemotherapy & Immunotherapy – Istituto Clinico Humanitas

Survival: 9.3 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Adriamycin
Country: Italy
City/State/Province: Milano
Hospital: Istituto Clinico Humanitas
Journal: Link
Date: 8/2001


Patients: This Phase II study involved 37 patients with malignant pleural mesothelioma who had not received chemotherapy or biological therapy before.

Treatment: The treatment consisted of the chemotherapy drugs cisplatin (platinol) and doxorubicin (adriamycin) with alpha-2b interferon.

Toxicity: Grade 4 toxicities included hematologic and renal.

Results: The median survival was 9.3 months.

Correspondence: Hector Soto Parra

Get your free copy of
“Surviving Mesothelioma” Today!